Sameera Fathimal M. , Janardanan Subramonia Kumar , Jeya Prabha A. , Jothiraj Selvaraj , Fabiola Jemmie Shilparani F. , Angeline Kirubha S.P.
{"title":"Potential of Near-Infrared Optical Techniques for Non-invasive Blood Glucose Measurement: A Pilot Study","authors":"Sameera Fathimal M. , Janardanan Subramonia Kumar , Jeya Prabha A. , Jothiraj Selvaraj , Fabiola Jemmie Shilparani F. , Angeline Kirubha S.P.","doi":"10.1016/j.irbm.2024.100870","DOIUrl":null,"url":null,"abstract":"<div><h3>Background</h3><div>Diabetes mellitus manifested by escalated blood glucose, demands periodic or continuous glucose monitoring in the pursuit of improved control, optimal management, and appropriate medication. The existing state-of-the-art for blood glucose estimation are invasive methodologies necessitating the acquisition of blood sample through either a finger-stick or venipuncture.</div></div><div><h3>Methods</h3><div>We propose a dual Near-infrared wavelength integrated in a 3D printed enclosure as the optical prototype for non-invasive glucose estimation. We acquired data from both diabetic and healthy subjects with the developed system and subsequently validated the system.</div></div><div><h3>Results</h3><div>The system demonstrated commendable clinical accuracy, as evidenced by the alignment of data pairs representing actual blood glucose levels and blood glucose levels predicted by our optical system within the A+B zones of the Parkes error grid and zones of no-risk and lower risk as defined by the surveillance error grid. We achieved compliant pairs percentage of 95.6%, which satisfies the accuracy requirements of the blood glucose monitoring surveillance study. The mean absolute percentage error attained with the proposed device (5.99%) was significant in predicting the blood glucose.</div></div><div><h3>Conclusion</h3><div>We successfully deployed the NIR wavelengths functionality as the promising approach for glucose monitoring, offering new possibilities for improved medical interventions.</div></div>","PeriodicalId":14605,"journal":{"name":"Irbm","volume":"46 1","pages":"Article 100870"},"PeriodicalIF":5.6000,"publicationDate":"2024-11-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Irbm","FirstCategoryId":"5","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S1959031824000514","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"ENGINEERING, BIOMEDICAL","Score":null,"Total":0}
引用次数: 0
Abstract
Background
Diabetes mellitus manifested by escalated blood glucose, demands periodic or continuous glucose monitoring in the pursuit of improved control, optimal management, and appropriate medication. The existing state-of-the-art for blood glucose estimation are invasive methodologies necessitating the acquisition of blood sample through either a finger-stick or venipuncture.
Methods
We propose a dual Near-infrared wavelength integrated in a 3D printed enclosure as the optical prototype for non-invasive glucose estimation. We acquired data from both diabetic and healthy subjects with the developed system and subsequently validated the system.
Results
The system demonstrated commendable clinical accuracy, as evidenced by the alignment of data pairs representing actual blood glucose levels and blood glucose levels predicted by our optical system within the A+B zones of the Parkes error grid and zones of no-risk and lower risk as defined by the surveillance error grid. We achieved compliant pairs percentage of 95.6%, which satisfies the accuracy requirements of the blood glucose monitoring surveillance study. The mean absolute percentage error attained with the proposed device (5.99%) was significant in predicting the blood glucose.
Conclusion
We successfully deployed the NIR wavelengths functionality as the promising approach for glucose monitoring, offering new possibilities for improved medical interventions.
期刊介绍:
IRBM is the journal of the AGBM (Alliance for engineering in Biology an Medicine / Alliance pour le génie biologique et médical) and the SFGBM (BioMedical Engineering French Society / Société française de génie biologique médical) and the AFIB (French Association of Biomedical Engineers / Association française des ingénieurs biomédicaux).
As a vehicle of information and knowledge in the field of biomedical technologies, IRBM is devoted to fundamental as well as clinical research. Biomedical engineering and use of new technologies are the cornerstones of IRBM, providing authors and users with the latest information. Its six issues per year propose reviews (state-of-the-art and current knowledge), original articles directed at fundamental research and articles focusing on biomedical engineering. All articles are submitted to peer reviewers acting as guarantors for IRBM''s scientific and medical content. The field covered by IRBM includes all the discipline of Biomedical engineering. Thereby, the type of papers published include those that cover the technological and methodological development in:
-Physiological and Biological Signal processing (EEG, MEG, ECG…)-
Medical Image processing-
Biomechanics-
Biomaterials-
Medical Physics-
Biophysics-
Physiological and Biological Sensors-
Information technologies in healthcare-
Disability research-
Computational physiology-
…